| Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling D Dunn, M Wallon, F Peyron, E Petersen, C Peckham, R Gilbert The Lancet 353 (9167), 1829-1833, 1999 | 936 | 1999 |
| Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe RE Gilbert, K Freeman, EG Lago, LMG Bahia-Oliveira, HK Tan, M Wallon, ... PLoS Neglected Tropical Diseases 2 (8), e277, 2008 | 358 | 2008 |
| Prenatal diagnosis using polymerase chain reaction on amniotic fluid for congenital toxoplasmosis S Romand, M Wallon, J Franck, P Thulliez, F Peyron, H Dumon Obstetrics & Gynecology 97 (2), 296-300, 2001 | 269 | 2001 |
| Congenital Toxoplasma Infection: Monthly Prenatal Screening Decreases Transmission Rate and Improves Clinical Outcome at Age 3 Years M Wallon, F Peyron, C Cornu, S Vinault, M Abrahamowicz, CB Kopp, ... Clinical Infectious Diseases 56 (9), 1223-1231, 2013 | 267 | 2013 |
| Long-term ocular prognosis in 327 children with congenital toxoplasmosis M Wallon, L Kodjikian, C Binquet, J Garweg, J Fleury, C Quantin, ... Pediatrics 113 (6), 1567-1572, 2004 | 258 | 2004 |
| Congenital toxoplasmosis: systematic review of evidence of efficacy of treatment in pregnancy M Wallon, C Liou, P Garner, F Peyron Bmj 318 (7197), 1511-1514, 1999 | 256 | 1999 |
| Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort study M Cortina-Borja, HK Tan, M Wallon, M Paul, A Prusa, W Buffolano, ... PLoS Medicine 7 (10), e1000351, 2010 | 235 | 2010 |
| Duration of the IgM response in women acquiring Toxoplasma gondii during pregnancy: implications for clinical practice and cross-sectional incidence studies L Gras, RE Gilbert, M Wallon, F Peyron, M Cortina-Borja Epidemiology & Infection 132 (3), 541-548, 2004 | 223 | 2004 |
| Congenital toxoplasmosis in France in 2007: first results from a national surveillance system I Villena, T Ancelle, C Delmas, P Garcia, AP Brezin, P Thulliez, M Wallon, ... Eurosurveillance 15 (25), 19600, 2010 | 208 | 2010 |
| Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centres L Gras, M Wallon, A Pollak, M Cortina‐borja, B Evengard, M Hayde, ... Acta paediatrica 94 (12), 1721-1731, 2005 | 193 | 2005 |
| Identification of Encephalitozoon intestinalis in Travelers with Chronic Diarrhea by Specific PCR Amplification L Raynaud, F Delbac, V Broussolle, M Rabodonirina, V Girault, M Wallon, ... Journal of Clinical Microbiology 36 (1), 37-40, 1998 | 178 | 1998 |
| Maternal and congenital toxoplasmosis: diagnosis and treatment recommendations of a French multidisciplinary working group F Peyron, C L’ollivier, L Mandelbrot, M Wallon, R Piarroux, F Kieffer, ... Pathogens 8 (1), 24, 2019 | 176 | 2019 |
| Usefulness of quantitative polymerase chain reaction in amniotic fluid as early prognostic marker of fetal infection with Toxoplasma gondii S Romand, M Chosson, J Franck, M Wallon, F Kieffer, K Kaiser, H Dumon, ... American journal of obstetrics and gynecology 190 (3), 797-802, 2004 | 171 | 2004 |
| Effect of prenatal treatment on mother to child transmission of Toxoplasma gondii: retrospective cohort study of 554 mother-child pairs in Lyon, France RE Gilbert, L Gras, M Wallon, F Peyron, AE Ades, DT Dunn International journal of epidemiology 30 (6), 1303-1308, 2001 | 160 | 2001 |
| Congenital toxoplasmosis F Kieffer, M Wallon Handbook of clinical neurology 112, 1099-1101, 2013 | 151 | 2013 |
| Accuracy of real-time polymerase chain reaction for Toxoplasma gondii in amniotic fluid M Wallon, J Franck, P Thulliez, C Huissoud, F Peyron, P Garcia-Meric, ... Obstetrics & Gynecology 115 (4), 727-733, 2010 | 144 | 2010 |
| Risk factors for retinochoroiditis during the first 2 years of life in infants with treated congenital toxoplasmosis F Kieffer, M Wallon, P Garcia, P Thulliez, F Peyron, J Franck The Pediatric infectious disease journal 27 (1), 27-32, 2008 | 140 | 2008 |
| Estimation of the avidity of immunoglobulin G for routine diagnosis of chronicToxoplasma gondii infection in pregnant women GJN Cozon, J Ferrandiz, H Nebhi, M Wallon, F Peyron European Journal of Clinical Microbiology and Infectious Diseases 17, 32-36, 1998 | 136 | 1998 |
| Genetic and Epigenetic Factors at COL2A1 and ABCA4 Influence Clinical Outcome in Congenital Toxoplasmosis SE Jamieson, LA de Roubaix, M Cortina-Borja, HK Tan, EJ Mui, ... PLoS One 3 (6), e2285, 2008 | 126 | 2008 |
| Treatments for toxoplasmosis in pregnancy F Peyron, M Wallon, C Liou, P Garner, ... Cochrane Database of Systematic Reviews 2010 (1), 1996 | 126 | 1996 |
